Biomea Fusion

Price & Volume

Stats

52W Range	$0.87-$3.08
Market Cap	$95.4M
Shares Short	12M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$1.18

News

Yahoo Finance • 16 days ago

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

Yahoo Finance • 4 months ago

Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025

Yahoo Finance • 4 months ago

Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

Yahoo Finance • 4 months ago

Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

About

CEO	Dr. Michael J. M. Hitchcock Ph.D.
Address	1599 Industrial Road, San Carlos, CA, United States, 94070
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	42